Specialized news

From a startup in France, Eurofins has grown into one of the world’s leading scientific groups, particularly in the field of biological testing, including medical testing, with over 900 laboratories worldwide. The integration of GENTIS into the Eurofins network marks a strategic turning point, ushering in a new era for genetic testing in Vietnam and Southeast Asia.

The ART ADVANCED 12 conference is a significant scientific event in the field of reproductive support organized by the Hanoi Reproductive Support Association. With the theme “New Perspectives on Reproductive Science: From Clinical Data to Personalized Treatment,” the conference will provide in-depth updates and important discussions about advances in reproductive support. This is an opportunity for experts to meet, share experiences, and move towards personalized treatment to improve clinical practice outcomes.

Recently, GENTIS collaborated with the Department of Andrology and Sexology at Hanoi University of Medicine to successfully organize a scientific seminar aimed at helping doctors and healthcare staff gain a better understanding of two specialized test packages: Whole Exome Sequencing (WES) and Sperm DNA Fragmentation.

In modern medicine, particularly in the diagnosis and screening of genetic diseases, the collaboration between clinical doctors, geneticists, and genetic laboratories plays an extremely important role. This is a closed-loop process that ensures patients receive accurate results, supporting the best treatment and prognosis possible.

Recently, GENTIS, in collaboration with An Viet General Hospital successfully held a scientific conference aimed at updating the information about 2 new PGT screening packages: PGT NEXT and PGT UPGRADE. At the event, a GENTIS representative provided detailed answers to the questions from doctors at the IVF An Viet Reproductive Center related these two advanced pre-implantation genetic testing packages.

Thalassemia is a recessive inherited anemia disorder on the autosomal chromosome, with the highest incidence rates globally, including in Vietnam. Thalassemia causes severe consequences for the material and mental well-being of affected individuals and their families. Currently, there is no definitive cure for this disease, but proactive prevention and screening are possible. Notably, the advent of Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) helps reduce the risk of having children affected by Thalassemia.

On the afternoon of March 6, GENTIS coordinated with the Post Office Hospital to organize a seminar introducing two newly launched PGT testing packages: PGT NEXT and PGT UPGRADE. Throughout the seminar, GENTIS representatives discussed and answered questions from doctors at the Post Office Hospital about these new genetic testing packages.